nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—ADRA1D—epithelium—cervical cancer	0.0117	0.0442	CbGeAlD
Cabergoline—ADRA1B—renal system—cervical cancer	0.0111	0.0419	CbGeAlD
Cabergoline—DRD5—female reproductive system—cervical cancer	0.0108	0.0409	CbGeAlD
Cabergoline—DRD5—female gonad—cervical cancer	0.00986	0.0372	CbGeAlD
Cabergoline—ADRA1D—female reproductive system—cervical cancer	0.00869	0.0328	CbGeAlD
Cabergoline—HTR2B—uterine cervix—cervical cancer	0.00806	0.0305	CbGeAlD
Cabergoline—HTR2B—decidua—cervical cancer	0.00768	0.029	CbGeAlD
Cabergoline—HTR2B—endometrium—cervical cancer	0.00729	0.0275	CbGeAlD
Cabergoline—HTR7—epithelium—cervical cancer	0.00696	0.0263	CbGeAlD
Cabergoline—HTR1A—renal system—cervical cancer	0.00676	0.0255	CbGeAlD
Cabergoline—HTR2B—uterus—cervical cancer	0.00672	0.0254	CbGeAlD
Cabergoline—ADRA1A—epithelium—cervical cancer	0.00672	0.0254	CbGeAlD
Cabergoline—HTR1B—female reproductive system—cervical cancer	0.00671	0.0253	CbGeAlD
Cabergoline—HTR1D—female reproductive system—cervical cancer	0.00649	0.0245	CbGeAlD
Cabergoline—HTR7—renal system—cervical cancer	0.00646	0.0244	CbGeAlD
Cabergoline—HTR2C—female reproductive system—cervical cancer	0.00643	0.0243	CbGeAlD
Cabergoline—ADRA2C—uterine cervix—cervical cancer	0.00635	0.024	CbGeAlD
Cabergoline—ADRB1—female reproductive system—cervical cancer	0.00631	0.0238	CbGeAlD
Cabergoline—ADRA1A—renal system—cervical cancer	0.00623	0.0235	CbGeAlD
Cabergoline—ADRA2C—decidua—cervical cancer	0.00605	0.0228	CbGeAlD
Cabergoline—HTR2B—female reproductive system—cervical cancer	0.00604	0.0228	CbGeAlD
Cabergoline—ADRA2C—renal system—cervical cancer	0.00594	0.0224	CbGeAlD
Cabergoline—ADRA2C—endometrium—cervical cancer	0.00574	0.0217	CbGeAlD
Cabergoline—ADRA2C—mammalian vulva—cervical cancer	0.00555	0.021	CbGeAlD
Cabergoline—HTR2B—vagina—cervical cancer	0.00546	0.0206	CbGeAlD
Cabergoline—ADRA2C—uterus—cervical cancer	0.00529	0.02	CbGeAlD
Cabergoline—HTR7—female reproductive system—cervical cancer	0.00517	0.0195	CbGeAlD
Cabergoline—ADRA2A—uterine cervix—cervical cancer	0.00506	0.0191	CbGeAlD
Cabergoline—ADRA2A—decidua—cervical cancer	0.00482	0.0182	CbGeAlD
Cabergoline—ADRA2A—endometrium—cervical cancer	0.00458	0.0173	CbGeAlD
Cabergoline—ADRA2A—mammalian vulva—cervical cancer	0.00443	0.0167	CbGeAlD
Cabergoline—HTR2A—epithelium—cervical cancer	0.00434	0.0164	CbGeAlD
Cabergoline—ADRA2C—female gonad—cervical cancer	0.00433	0.0163	CbGeAlD
Cabergoline—ADRA2C—vagina—cervical cancer	0.0043	0.0162	CbGeAlD
Cabergoline—ADRA2A—uterus—cervical cancer	0.00422	0.0159	CbGeAlD
Cabergoline—HTR2A—renal system—cervical cancer	0.00403	0.0152	CbGeAlD
Cabergoline—ADRA2A—female reproductive system—cervical cancer	0.00379	0.0143	CbGeAlD
Cabergoline—CYP3A4—renal system—cervical cancer	0.00373	0.0141	CbGeAlD
Cabergoline—HTR2B—lymph node—cervical cancer	0.00353	0.0133	CbGeAlD
Cabergoline—ADRA2A—female gonad—cervical cancer	0.00345	0.013	CbGeAlD
Cabergoline—ADRA2A—vagina—cervical cancer	0.00343	0.013	CbGeAlD
Cabergoline—HTR2A—female reproductive system—cervical cancer	0.00323	0.0122	CbGeAlD
Cabergoline—CYP3A4—female reproductive system—cervical cancer	0.00299	0.0113	CbGeAlD
Cabergoline—HTR2A—vagina—cervical cancer	0.00292	0.011	CbGeAlD
Cabergoline—ADRA2C—lymph node—cervical cancer	0.00278	0.0105	CbGeAlD
Cabergoline—ADRA2A—lymph node—cervical cancer	0.00222	0.00838	CbGeAlD
Cabergoline—Pleural effusion—Topotecan—cervical cancer	0.00161	0.088	CcSEcCtD
Cabergoline—Dysmenorrhoea—Topotecan—cervical cancer	0.00135	0.0741	CcSEcCtD
Cabergoline—Respiratory failure—Topotecan—cervical cancer	0.00125	0.0686	CcSEcCtD
Cabergoline—Weight increased—Topotecan—cervical cancer	0.000703	0.0385	CcSEcCtD
Cabergoline—Pneumonia—Topotecan—cervical cancer	0.000693	0.0379	CcSEcCtD
Cabergoline—Epistaxis—Topotecan—cervical cancer	0.00065	0.0356	CcSEcCtD
Cabergoline—Rhinitis—Topotecan—cervical cancer	0.00062	0.0339	CcSEcCtD
Cabergoline—Alopecia—Topotecan—cervical cancer	0.000546	0.0299	CcSEcCtD
Cabergoline—Back pain—Topotecan—cervical cancer	0.000521	0.0285	CcSEcCtD
Cabergoline—Muscle spasms—Topotecan—cervical cancer	0.000517	0.0283	CcSEcCtD
Cabergoline—Ill-defined disorder—Topotecan—cervical cancer	0.000499	0.0273	CcSEcCtD
Cabergoline—Malaise—Topotecan—cervical cancer	0.000485	0.0266	CcSEcCtD
Cabergoline—Arthralgia—Topotecan—cervical cancer	0.000458	0.0251	CcSEcCtD
Cabergoline—Discomfort—Topotecan—cervical cancer	0.000453	0.0248	CcSEcCtD
Cabergoline—Hyperhidrosis—Topotecan—cervical cancer	0.000425	0.0232	CcSEcCtD
Cabergoline—Anorexia—Topotecan—cervical cancer	0.000419	0.0229	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Topotecan—cervical cancer	0.0004	0.0219	CcSEcCtD
Cabergoline—Paraesthesia—Topotecan—cervical cancer	0.000394	0.0216	CcSEcCtD
Cabergoline—Dyspnoea—Topotecan—cervical cancer	0.000392	0.0214	CcSEcCtD
Cabergoline—Dyspepsia—Topotecan—cervical cancer	0.000387	0.0212	CcSEcCtD
Cabergoline—Decreased appetite—Topotecan—cervical cancer	0.000382	0.0209	CcSEcCtD
Cabergoline—Fatigue—Topotecan—cervical cancer	0.000379	0.0207	CcSEcCtD
Cabergoline—Pain—Topotecan—cervical cancer	0.000376	0.0206	CcSEcCtD
Cabergoline—Constipation—Topotecan—cervical cancer	0.000376	0.0206	CcSEcCtD
Cabergoline—Feeling abnormal—Topotecan—cervical cancer	0.000362	0.0198	CcSEcCtD
Cabergoline—Gastrointestinal pain—Topotecan—cervical cancer	0.000359	0.0197	CcSEcCtD
Cabergoline—Abdominal pain—Topotecan—cervical cancer	0.000347	0.019	CcSEcCtD
Cabergoline—Hypersensitivity—Topotecan—cervical cancer	0.000324	0.0177	CcSEcCtD
Cabergoline—Asthenia—Topotecan—cervical cancer	0.000315	0.0173	CcSEcCtD
Cabergoline—Pruritus—Topotecan—cervical cancer	0.000311	0.017	CcSEcCtD
Cabergoline—Diarrhoea—Topotecan—cervical cancer	0.000301	0.0165	CcSEcCtD
Cabergoline—Dizziness—Topotecan—cervical cancer	0.00029	0.0159	CcSEcCtD
Cabergoline—HTR7—Signaling Pathways—NOTCH2—cervical cancer	0.000283	0.000394	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	0.000281	0.000392	CbGpPWpGaD
Cabergoline—Vomiting—Topotecan—cervical cancer	0.000279	0.0153	CcSEcCtD
Cabergoline—Rash—Topotecan—cervical cancer	0.000277	0.0152	CcSEcCtD
Cabergoline—Dermatitis—Topotecan—cervical cancer	0.000277	0.0151	CcSEcCtD
Cabergoline—Headache—Topotecan—cervical cancer	0.000275	0.0151	CcSEcCtD
Cabergoline—HTR1B—Signaling Pathways—NOTCH2—cervical cancer	0.000275	0.000384	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000272	0.000379	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—NOTCH2—cervical cancer	0.000271	0.000378	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—TERT—cervical cancer	0.000264	0.000368	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000262	0.000366	CbGpPWpGaD
Cabergoline—Nausea—Topotecan—cervical cancer	0.000261	0.0143	CcSEcCtD
Cabergoline—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.000258	0.00036	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000258	0.00036	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.000253	0.000352	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000244	0.00034	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—FGFR3—cervical cancer	0.000242	0.000337	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.00024	0.000335	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.00024	0.000335	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000235	0.000327	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—HES1—cervical cancer	0.000232	0.000323	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—HES1—cervical cancer	0.00023	0.000321	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—NOTCH1—cervical cancer	0.000227	0.000317	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—HES1—cervical cancer	0.000226	0.000315	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—HES1—cervical cancer	0.000222	0.00031	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—NOTCH2—cervical cancer	0.000219	0.000306	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000217	0.000303	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—NOTCH2—cervical cancer	0.000214	0.000299	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—HES1—cervical cancer	0.000212	0.000295	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.00021	0.000292	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000208	0.000291	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TERT—cervical cancer	0.000203	0.000283	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.000203	0.000283	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—EGFR—cervical cancer	0.000202	0.000282	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TERT—cervical cancer	0.000202	0.000282	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—HES1—cervical cancer	0.0002	0.000279	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.0002	0.000278	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TERT—cervical cancer	0.000198	0.000276	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—HES1—cervical cancer	0.000197	0.000275	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—HES1—cervical cancer	0.000197	0.000275	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TERT—cervical cancer	0.000194	0.000271	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—FGFR3—cervical cancer	0.000186	0.00026	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TERT—cervical cancer	0.000186	0.000259	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—FGFR3—cervical cancer	0.000185	0.000258	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000184	0.000257	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—FGFR3—cervical cancer	0.000181	0.000253	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000181	0.000252	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—HES1—cervical cancer	0.00018	0.000251	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—FGFR3—cervical cancer	0.000178	0.000249	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000178	0.000248	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000177	0.000247	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—HES1—cervical cancer	0.000176	0.000245	CbGpPWpGaD
Cabergoline—ADRA2B—Hemostasis—TP53—cervical cancer	0.000175	0.000244	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TERT—cervical cancer	0.000175	0.000244	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—NOTCH1—cervical cancer	0.000175	0.000244	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—MTHFR—cervical cancer	0.000175	0.000244	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	0.000174	0.000243	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TERT—cervical cancer	0.000173	0.000241	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TERT—cervical cancer	0.000173	0.000241	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000172	0.00024	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000171	0.000238	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—FGFR3—cervical cancer	0.00017	0.000238	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	0.00017	0.000237	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—MTOR—cervical cancer	0.00017	0.000237	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—NOTCH1—cervical cancer	0.000168	0.000234	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.000166	0.000232	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000165	0.00023	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—HES1—cervical cancer	0.000164	0.000228	CbGpPWpGaD
Cabergoline—ADRA2C—Hemostasis—TP53—cervical cancer	0.000164	0.000228	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000161	0.000224	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	0.00016	0.000223	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.000159	0.000221	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	0.000159	0.000221	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TERT—cervical cancer	0.000157	0.00022	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—CASP3—cervical cancer	0.000156	0.000218	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TERT—cervical cancer	0.000156	0.000218	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—EGFR—cervical cancer	0.000156	0.000218	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—EGFR—cervical cancer	0.000155	0.000216	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TERT—cervical cancer	0.000154	0.000215	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—EGFR—cervical cancer	0.000152	0.000212	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—HES1—cervical cancer	0.000151	0.00021	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.000151	0.00021	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—CTNNB1—cervical cancer	0.000151	0.00021	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TERT—cervical cancer	0.000151	0.00021	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TERT—cervical cancer	0.00015	0.000209	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—EGFR—cervical cancer	0.000149	0.000208	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CA9—cervical cancer	0.000149	0.000208	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	0.000149	0.000208	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—NOTCH1—cervical cancer	0.000149	0.000208	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000148	0.000207	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TERT—cervical cancer	0.000146	0.000203	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—HES1—cervical cancer	0.000145	0.000203	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—FGFR3—cervical cancer	0.000144	0.000201	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TERT—cervical cancer	0.000143	0.0002	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	0.000143	0.0002	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—EGFR—cervical cancer	0.000143	0.000199	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000142	0.000198	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—FGFR3—cervical cancer	0.000141	0.000197	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000138	0.000193	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000137	0.000192	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—NOTCH1—cervical cancer	0.000136	0.000189	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000135	0.000188	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—EGFR—cervical cancer	0.000134	0.000187	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	0.000134	0.000187	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	0.000134	0.000186	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—TP53—cervical cancer	0.000133	0.000185	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—NOTCH1—cervical cancer	0.000133	0.000185	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—EGFR—cervical cancer	0.000133	0.000185	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	0.000133	0.000185	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TERT—cervical cancer	0.000132	0.000184	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	0.000132	0.000184	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—STAT3—cervical cancer	0.000131	0.000183	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—MTOR—cervical cancer	0.000131	0.000183	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—MTOR—cervical cancer	0.00013	0.000182	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TERT—cervical cancer	0.00013	0.000181	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	0.00013	0.000181	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.000129	0.00018	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—MTOR—cervical cancer	0.000128	0.000178	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TERT—cervical cancer	0.000127	0.000178	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—MTOR—cervical cancer	0.000126	0.000175	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	0.000126	0.000175	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	0.000124	0.000172	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000121	0.000169	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—EGFR—cervical cancer	0.000121	0.000169	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CASP3—cervical cancer	0.000121	0.000168	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MTOR—cervical cancer	0.00012	0.000167	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CASP3—cervical cancer	0.00012	0.000167	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	0.00012	0.000167	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—EGFR—cervical cancer	0.000119	0.000167	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000119	0.000166	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000118	0.000165	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—EGFR—cervical cancer	0.000118	0.000165	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CASP3—cervical cancer	0.000117	0.000164	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	0.000117	0.000163	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CTNNB1—cervical cancer	0.000116	0.000162	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—EGFR—cervical cancer	0.000116	0.000161	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	0.000116	0.000161	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CASP3—cervical cancer	0.000115	0.000161	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—EGFR—cervical cancer	0.000115	0.00016	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—NOTCH1—cervical cancer	0.000114	0.000159	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	0.000113	0.000158	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MTOR—cervical cancer	0.000113	0.000158	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000112	0.000156	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	0.000112	0.000156	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MTOR—cervical cancer	0.000112	0.000156	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MTOR—cervical cancer	0.000112	0.000156	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CTNNB1—cervical cancer	0.000111	0.000155	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CASP3—cervical cancer	0.00011	0.000154	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	0.00011	0.000153	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	0.00011	0.000153	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	0.000109	0.000151	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	0.000106	0.000148	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CASP3—cervical cancer	0.000104	0.000145	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CASP3—cervical cancer	0.000103	0.000143	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CASP3—cervical cancer	0.000103	0.000143	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	0.000102	0.000142	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MTOR—cervical cancer	0.000102	0.000142	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—EGFR—cervical cancer	0.000101	0.000142	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—STAT3—cervical cancer	0.000101	0.000141	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—STAT3—cervical cancer	0.000101	0.00014	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MTOR—cervical cancer	0.000101	0.00014	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—TP53—cervical cancer	0.0001	0.00014	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CTNNB1—cervical cancer	0.0001	0.00014	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—EGFR—cervical cancer	9.98e-05	0.000139	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MTOR—cervical cancer	9.94e-05	0.000139	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CTNNB1—cervical cancer	9.89e-05	0.000138	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	9.89e-05	0.000138	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—STAT3—cervical cancer	9.86e-05	0.000138	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	9.78e-05	0.000136	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MTOR—cervical cancer	9.72e-05	0.000136	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—STAT3—cervical cancer	9.7e-05	0.000135	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MTOR—cervical cancer	9.67e-05	0.000135	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MTOR—cervical cancer	9.4e-05	0.000131	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CASP3—cervical cancer	9.35e-05	0.00013	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—STAT3—cervical cancer	9.26e-05	0.000129	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CASP3—cervical cancer	9.26e-05	0.000129	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MTOR—cervical cancer	9.26e-05	0.000129	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—EGFR—cervical cancer	9.21e-05	0.000128	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—EGFR—cervical cancer	9.15e-05	0.000128	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CASP3—cervical cancer	9.14e-05	0.000128	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	9.08e-05	0.000127	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CTNNB1—cervical cancer	9.01e-05	0.000126	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—EGFR—cervical cancer	8.96e-05	0.000125	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CASP3—cervical cancer	8.94e-05	0.000125	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	8.93e-05	0.000124	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CASP3—cervical cancer	8.89e-05	0.000124	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—EGFR—cervical cancer	8.82e-05	0.000123	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CTNNB1—cervical cancer	8.81e-05	0.000123	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—STAT3—cervical cancer	8.73e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CASP3—cervical cancer	8.65e-05	0.000121	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—STAT3—cervical cancer	8.62e-05	0.00012	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—STAT3—cervical cancer	8.62e-05	0.00012	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	8.62e-05	0.00012	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	8.57e-05	0.00012	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MTOR—cervical cancer	8.53e-05	0.000119	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CASP3—cervical cancer	8.51e-05	0.000119	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—EGFR—cervical cancer	8.42e-05	0.000117	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MTOR—cervical cancer	8.4e-05	0.000117	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	8.34e-05	0.000116	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MTOR—cervical cancer	8.22e-05	0.000115	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	8.21e-05	0.000114	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—EGFR—cervical cancer	7.94e-05	0.000111	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—STAT3—cervical cancer	7.85e-05	0.00011	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CASP3—cervical cancer	7.85e-05	0.000109	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—EGFR—cervical cancer	7.83e-05	0.000109	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—EGFR—cervical cancer	7.83e-05	0.000109	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—STAT3—cervical cancer	7.78e-05	0.000109	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TP53—cervical cancer	7.73e-05	0.000108	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CASP3—cervical cancer	7.72e-05	0.000108	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TP53—cervical cancer	7.68e-05	0.000107	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—STAT3—cervical cancer	7.68e-05	0.000107	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MTOR—cervical cancer	7.64e-05	0.000107	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CTNNB1—cervical cancer	7.57e-05	0.000106	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CASP3—cervical cancer	7.56e-05	0.000105	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TP53—cervical cancer	7.52e-05	0.000105	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—STAT3—cervical cancer	7.51e-05	0.000105	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—STAT3—cervical cancer	7.47e-05	0.000104	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	7.44e-05	0.000104	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TP53—cervical cancer	7.4e-05	0.000103	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	7.29e-05	0.000102	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—STAT3—cervical cancer	7.27e-05	0.000101	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—STAT3—cervical cancer	7.15e-05	9.98e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—EGFR—cervical cancer	7.14e-05	9.95e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—EGFR—cervical cancer	7.07e-05	9.86e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TP53—cervical cancer	7.07e-05	9.86e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CASP3—cervical cancer	7.03e-05	9.8e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—EGFR—cervical cancer	6.98e-05	9.74e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—EGFR—cervical cancer	6.83e-05	9.52e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—EGFR—cervical cancer	6.79e-05	9.47e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	6.77e-05	9.45e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TP53—cervical cancer	6.67e-05	9.3e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—EGFR—cervical cancer	6.61e-05	9.21e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—STAT3—cervical cancer	6.59e-05	9.2e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TP53—cervical cancer	6.58e-05	9.17e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TP53—cervical cancer	6.58e-05	9.17e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—EGFR—cervical cancer	6.5e-05	9.07e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—STAT3—cervical cancer	6.49e-05	9.05e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—STAT3—cervical cancer	6.35e-05	8.86e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MTHFR—cervical cancer	6.05e-05	8.43e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—EGFR—cervical cancer	5.99e-05	8.36e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TP53—cervical cancer	5.99e-05	8.36e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TP53—cervical cancer	5.94e-05	8.28e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—STAT3—cervical cancer	5.9e-05	8.23e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—EGFR—cervical cancer	5.9e-05	8.23e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TP53—cervical cancer	5.86e-05	8.18e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—EGFR—cervical cancer	5.77e-05	8.05e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TP53—cervical cancer	5.73e-05	7.99e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TP53—cervical cancer	5.7e-05	7.95e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TP53—cervical cancer	5.55e-05	7.74e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TP53—cervical cancer	5.46e-05	7.61e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—EGFR—cervical cancer	5.37e-05	7.48e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TP53—cervical cancer	5.03e-05	7.02e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TP53—cervical cancer	4.95e-05	6.91e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TP53—cervical cancer	4.85e-05	6.76e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TP53—cervical cancer	4.51e-05	6.28e-05	CbGpPWpGaD
